JPMORGAN CHASE & CO - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,404
-77.3%
12,808
-40.3%
0.00%
Q2 2023$142,790
-55.7%
21,440
+24.0%
0.00%
Q1 2023$322,000
+129217.3%
17,291
+49.1%
0.00%
Q4 2022$249
-99.8%
11,595
+9.5%
0.00%
Q3 2022$126,000
-8.0%
10,589
+2.0%
0.00%
Q2 2022$137,000
-51.8%
10,378
-23.7%
0.00%
Q1 2022$284,000
+19.3%
13,606
+15.9%
0.00%
Q4 2021$238,000
-28.3%
11,736
+7.1%
0.00%
Q3 2021$332,000
+20.3%
10,953
+15.5%
0.00%
Q2 2021$276,000
-22.0%
9,481
+15.5%
0.00%
Q1 2021$354,000
+32.1%
8,212
+41.4%
0.00%
Q4 2020$268,000
+42.6%
5,807
+32.7%
0.00%
Q3 2020$188,000
-0.5%
4,375
+22.7%
0.00%
Q2 2020$189,000
+278.0%
3,565
+60.4%
0.00%
Q1 2020$50,000
-62.7%
2,222
-75.7%
0.00%
Q4 2019$134,000
+857.1%
9,144
+362.5%
0.00%
Q3 2019$14,000
-22.2%
1,977
+19.4%
0.00%
Q2 2019$18,0001,6560.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders